{
    "clinical_study": {
        "@rank": "55434", 
        "arm_group": [
            {
                "arm_group_label": "Holter monitoring", 
                "arm_group_type": "Other", 
                "description": "Screening of patients with older age, arterial hypertension and diabetes for paroxysmal atrial fibrillation by using conventional Holter monitoring"
            }, 
            {
                "arm_group_label": "Implantable loop recorder", 
                "arm_group_type": "Other", 
                "description": "Screening of patients with older age, arterial hypertension and diabetes mellitus for paroxysmal atrial fibrillation by using an implantable loop recorder"
            }
        ], 
        "brief_summary": {
            "textblock": "Using implantable loop recorder the investigators wish to detect atrial fibrillation in high\n      risk patients and compare it to the results using conventional Holter monitoring. The\n      hypothesis is that 10-15% of high risk patients have subclinical atrial fibrillation. The\n      investigators want to detect those people so they can receive appropriate anticoagulation\n      treatment. The patients will get a comprehensive workup including ecg, echocardiography and\n      blood tests."
        }, 
        "brief_title": "Detection of Subclinical Atrial Fibrillation in High Risk Patients Using Implantable Loop Recorder", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Arterial Hypertension", 
            "Diabetes Mellitus"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Diabetes Mellitus", 
                "Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age > 65 years\n\n          -  arterial hypertension (at least dual treatment)\n\n          -  diabetes mellitus (oral antidiabetics or insulin)\n\n        Exclusion Criteria:\n\n          -  known atrial fibrillation\n\n          -  ischaemic heart disease\n\n          -  Current anticoagulation treatment\n\n          -  Ejection fraction <45 %\n\n          -  significant valvular heart disease\n\n          -  previous stroke/transient ischemic attack\n\n          -  peripheral arterial disease\n\n          -  end stage renal disease\n\n          -  thyreotoxicosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02041832", 
            "org_study_id": "ILR-Afib-study", 
            "secondary_id": "S-20130062"
        }, 
        "intervention": [
            {
                "arm_group_label": "Holter monitoring", 
                "description": "Patients undergo 72h Holter monitoring", 
                "intervention_name": "Conventional Holter monitoring", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Implantable loop recorder", 
                "description": "Implantation of loop recorder with follow-up by remote monitoring", 
                "intervention_name": "Implantable loop recorder", 
                "intervention_type": "Device", 
                "other_name": "REVEAL XT"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 18, 2014", 
        "location": {
            "contact": {
                "email": "tinephilippsen@gmail.com", 
                "last_name": "Tine J Philippsen, MD", 
                "phone": "004525884271"
            }, 
            "facility": {
                "address": {
                    "city": "Haderslev", 
                    "country": "Denmark", 
                    "zip": "6100"
                }, 
                "name": "Haderslev Hospital"
            }, 
            "investigator": {
                "last_name": "Tine J Philippsen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Detection of Subclinical Atrial Fibrillation in High Risk Patients (> 65 Years, Hypertension, Diabetes Mellitus) Using Implantable Loop Recorder", 
        "other_outcome": {
            "measure": "Correlation between biomarkers and incidence of atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_contact": {
            "email": "tinephilippsen@gmail.com", 
            "last_name": "Tine J Philippsen, MD", 
            "phone": "004525884271"
        }, 
        "overall_contact_backup": {
            "email": "axbr@rsyd.dk", 
            "last_name": "Axel Brandes, MD, DMSc", 
            "phone": "004565415132"
        }, 
        "overall_official": {
            "affiliation": "Odense University Hospital/University of Southern Denmark", 
            "last_name": "Axel Brandes, Assoc. Prof.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "First episode of atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02041832"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Odense University Hospital", 
            "investigator_full_name": "Axel Brandes", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Correlation between echocardiographic parameters and incidence of atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Odense University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Axel Brandes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}